Skip to main content
Erschienen in: Endocrine 3/2016

21.03.2016 | Original Article

Morning cortisol levels and glucose metabolism parameters in moderate and severe obstructive sleep apnea patients

verfasst von: Josko Bozic, Tea Galic, Daniela Supe-Domic, Natalija Ivkovic, Tina Ticinovic Kurir, Zoran Valic, Josip Lesko, Zoran Dogas

Erschienen in: Endocrine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Obstructive sleep apnea (OSA) has been associated with dysregulation of the hypothalamic–pituitary–adrenal axis and alterations in glucose metabolism with increased risk for type 2 diabetes. The aim of the current study was to compare morning plasma cortisol levels and glucose metabolism parameters between moderate (apnea–hypopnea index (AHI): 15–30 events/h) and severe OSA patients (AHI >30 events/h), with respective controls. A total of 56 male OSA patients, 24 moderate (AHI = 21.1 ± 5.3) and 32 severe (AHI = 49.7 ± 18.1), underwent a full-night polysomnography, oral glucose tolerance test (OGTT), and measurement of morning plasma cortisol levels. These groups were compared to 20 matched subjects in a control group. Morning plasma cortisol levels were statistically lower in severe OSA group than in moderate OSA and control groups (303.7 ± 93.5 vs. 423.9 ± 145.1 vs. 417.5 ± 99.8 pmol/L, P < 0.001). Significant negative correlations were found between morning plasma cortisol levels and AHI (r = −0.444, P = 0.002), as well as oxygen desaturation index (r = −0.381, P = 0.011). Fasting plasma glucose (5.0 ± 0.5 vs. 5.4 ± 0.7 vs. 4.9 ± 0.6 mmol/L, P = 0.009) was higher in the severe OSA group compared to moderate OSA and controls. Homeostasis model assessment insulin resistance (HOMA-IR) was higher in the severe OSA group compared to moderate OSA and controls (4.6 ± 3.7 vs. 2.7 ± 2.0 and 2.2 ± 1.8, respectively, P = 0.006). In conclusion, our study showed that morning plasma cortisol levels measured at 8 a.m. were significantly lower in severe OSA patients than those in moderate OSA group and controls. Morning plasma cortisol levels showed a negative correlation with AHI and oxygen desaturation index. Additionally, this study confirmed the evidence of glucose metabolism impairment in moderate and severe OSA patients, with more pronounced effect in the severe OSA patients group.
Literatur
1.
Zurück zum Zitat A.S. Jordan, D.G. McSharry, A. Malhorta, Adult obstructive sleep apnoea. Lancet 383, 736–747 (2014)CrossRefPubMed A.S. Jordan, D.G. McSharry, A. Malhorta, Adult obstructive sleep apnoea. Lancet 383, 736–747 (2014)CrossRefPubMed
2.
Zurück zum Zitat C. Guilleminault, L. Eldridge, A. Tilkian, B. Simmons, W. Dement, Sleep apnoea syndrome due to upper airway obstruction. Arch. Intern. Med. 137, 296–300 (1997)CrossRef C. Guilleminault, L. Eldridge, A. Tilkian, B. Simmons, W. Dement, Sleep apnoea syndrome due to upper airway obstruction. Arch. Intern. Med. 137, 296–300 (1997)CrossRef
3.
Zurück zum Zitat W.T. McNicholas, Sleep-related breathing disorders: nosological classification, definitions, epidemiology, in Sleep Medicine Textbook, ed. by C. Bassetti, Z. Dogas, P. Peigneux (European Sleep Research Society, Regensburg, 2014), pp. 215–220 W.T. McNicholas, Sleep-related breathing disorders: nosological classification, definitions, epidemiology, in Sleep Medicine Textbook, ed. by C. Bassetti, Z. Dogas, P. Peigneux (European Sleep Research Society, Regensburg, 2014), pp. 215–220
5.
Zurück zum Zitat K. Stamatakis, M.H. Sanders, B. Caffo et al., Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 31, 1018–1024 (2008)PubMedPubMedCentral K. Stamatakis, M.H. Sanders, B. Caffo et al., Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 31, 1018–1024 (2008)PubMedPubMedCentral
6.
Zurück zum Zitat J.L. Pepin, J.C. Borel, A.L. Borel, P. Levy, R. Tamisier, Sleep-related breathing disorders: comorbidities and special populations, in Sleep Medicine Textbook, ed. by C. Bassetti, Z. Dogas, P. Peigneux (European Sleep Research Society, Regensburg, 2014), pp. 251–258 J.L. Pepin, J.C. Borel, A.L. Borel, P. Levy, R. Tamisier, Sleep-related breathing disorders: comorbidities and special populations, in Sleep Medicine Textbook, ed. by C. Bassetti, Z. Dogas, P. Peigneux (European Sleep Research Society, Regensburg, 2014), pp. 251–258
7.
Zurück zum Zitat M.L. Tomfohr, K.M. Edwards, J.E. Dimsdale, Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. Sleep Med. Rev. 16, 243–249 (2012)CrossRefPubMed M.L. Tomfohr, K.M. Edwards, J.E. Dimsdale, Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. Sleep Med. Rev. 16, 243–249 (2012)CrossRefPubMed
9.
Zurück zum Zitat S. Khani, J.A. Tayek, Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin. Sci. 101, 739–747 (2001)CrossRefPubMed S. Khani, J.A. Tayek, Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin. Sci. 101, 739–747 (2001)CrossRefPubMed
10.
Zurück zum Zitat Z. Lattova, M. Keckeis, E. Maurovich-Horvat et al., The stress hormone system in various sleep disorders. J. Psychiatr. Res. 45, 1223–1228 (2011)PubMed Z. Lattova, M. Keckeis, E. Maurovich-Horvat et al., The stress hormone system in various sleep disorders. J. Psychiatr. Res. 45, 1223–1228 (2011)PubMed
11.
Zurück zum Zitat E. Crawford-Achour, M. Saint Martin, F. Roche, Stress hormones in obstructive sleep apnea complications: the role of cortisol. Sleep Med. 15, 3–4 (2014)CrossRefPubMed E. Crawford-Achour, M. Saint Martin, F. Roche, Stress hormones in obstructive sleep apnea complications: the role of cortisol. Sleep Med. 15, 3–4 (2014)CrossRefPubMed
12.
Zurück zum Zitat S.L. Appleton, A. Vakulin, R.D. McEvoy et al., Nocturnal hypoxemia and severe obstructive sleep apnea are associated with incident type 2 diabetes in a population cohort of men. J. Clin. Sleep Med. 11, 609–614 (2015)PubMedPubMedCentral S.L. Appleton, A. Vakulin, R.D. McEvoy et al., Nocturnal hypoxemia and severe obstructive sleep apnea are associated with incident type 2 diabetes in a population cohort of men. J. Clin. Sleep Med. 11, 609–614 (2015)PubMedPubMedCentral
13.
Zurück zum Zitat N.H. Kim, N.H. Cho, C.H. Yun et al., Association of obstructive sleep apnea and glucose metabolism in subjects with or without obesity. Diabetes Care 36, 3909–3915 (2013)CrossRefPubMedPubMedCentral N.H. Kim, N.H. Cho, C.H. Yun et al., Association of obstructive sleep apnea and glucose metabolism in subjects with or without obesity. Diabetes Care 36, 3909–3915 (2013)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat S. Seicean, H.L. Kirchner, D.J. Gottlieb et al., Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals. Diabetes Care 31, 1001–1006 (2008)CrossRefPubMed S. Seicean, H.L. Kirchner, D.J. Gottlieb et al., Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals. Diabetes Care 31, 1001–1006 (2008)CrossRefPubMed
15.
Zurück zum Zitat N.M. Punjabi, V.Y. Polotsky, Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 99, 1998–2007 (2005)CrossRefPubMed N.M. Punjabi, V.Y. Polotsky, Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 99, 1998–2007 (2005)CrossRefPubMed
16.
Zurück zum Zitat A.A. Tahrani, A. Ali, M.J. Stevens, Obstructive sleep apnoea and diabetes: an update. Curr. Opin. Pulm. Med. 19, 631–638 (2013)CrossRefPubMed A.A. Tahrani, A. Ali, M.J. Stevens, Obstructive sleep apnoea and diabetes: an update. Curr. Opin. Pulm. Med. 19, 631–638 (2013)CrossRefPubMed
17.
Zurück zum Zitat X. Wang, Y. Bi, Q. Zhang, F. Pan, Obstructive sleep apnea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Respirology 18, 140–146 (2013)CrossRefPubMed X. Wang, Y. Bi, Q. Zhang, F. Pan, Obstructive sleep apnea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Respirology 18, 140–146 (2013)CrossRefPubMed
18.
Zurück zum Zitat L.F. Drager, S.M. Togeiro, V.Y. Polotsky, G. Lorenzi-Filho, Obstructive sleep apnea: a cardiovascular risk in obesity and metabolic syndrome. J. Am. Coll. Cardiol. 62, 569–576 (2013)CrossRefPubMedPubMedCentral L.F. Drager, S.M. Togeiro, V.Y. Polotsky, G. Lorenzi-Filho, Obstructive sleep apnea: a cardiovascular risk in obesity and metabolic syndrome. J. Am. Coll. Cardiol. 62, 569–576 (2013)CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat B.D. Kent, L. Grote, S. Ryan et al., Diabetes mellitus prevalence and control in sleep disordered breathing: the European sleep apnea cohort (ESADA) study. Chest 146, 982–990 (2014)CrossRefPubMed B.D. Kent, L. Grote, S. Ryan et al., Diabetes mellitus prevalence and control in sleep disordered breathing: the European sleep apnea cohort (ESADA) study. Chest 146, 982–990 (2014)CrossRefPubMed
20.
Zurück zum Zitat The Report of an American Academy of Sleep Medicine Task Force, Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22, 667–689 (1999) The Report of an American Academy of Sleep Medicine Task Force, Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22, 667–689 (1999)
21.
Zurück zum Zitat L.J. Epstein, D. Kristo, P.J. Strollo Jr et al., Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J. Clin. Sleep Med. 5, 263–276 (2009)PubMed L.J. Epstein, D. Kristo, P.J. Strollo Jr et al., Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J. Clin. Sleep Med. 5, 263–276 (2009)PubMed
22.
Zurück zum Zitat R. Pecotic, I.P. Dodig, M. Valic, N. Ivkovic, Z. Dogas, The evaluation of the Croatian version of the Epworth sleepiness scale and STOP questionnaire as screening tools for obstructive sleep apnea syndrome. Sleep Breath. 16, 793–802 (2012)CrossRefPubMed R. Pecotic, I.P. Dodig, M. Valic, N. Ivkovic, Z. Dogas, The evaluation of the Croatian version of the Epworth sleepiness scale and STOP questionnaire as screening tools for obstructive sleep apnea syndrome. Sleep Breath. 16, 793–802 (2012)CrossRefPubMed
23.
Zurück zum Zitat J. Fischer, Z. Dogas, C.L. Bassetti et al., Standard procedures for adults in accredited sleep medicine centres in Europe. J. Sleep Res. 21, 357–368 (2012)CrossRefPubMed J. Fischer, Z. Dogas, C.L. Bassetti et al., Standard procedures for adults in accredited sleep medicine centres in Europe. J. Sleep Res. 21, 357–368 (2012)CrossRefPubMed
24.
Zurück zum Zitat C.A. Kushida, M.R. Littner, T. Morgenthaler et al., Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28, 449–521 (2005) C.A. Kushida, M.R. Littner, T. Morgenthaler et al., Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28, 449–521 (2005)
25.
Zurück zum Zitat American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 35, 64–71 (2012)CrossRef American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 35, 64–71 (2012)CrossRef
26.
Zurück zum Zitat American Diabetes Association, Standards of medical care in diabetes—2014. Diabetes Care 37, 14–80 (2014)CrossRef American Diabetes Association, Standards of medical care in diabetes—2014. Diabetes Care 37, 14–80 (2014)CrossRef
27.
Zurück zum Zitat D.R. Matthews, J.P. Hosker, A.S. Rudenski et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRefPubMed
28.
Zurück zum Zitat H. Raff, S.L. Ettema, D.C. Eastwood, B.T. Woodson, Salivary cortisol in obstructive sleep apnea: the effect of CPAP. Endocrine 40, 137–139 (2011)CrossRefPubMedPubMedCentral H. Raff, S.L. Ettema, D.C. Eastwood, B.T. Woodson, Salivary cortisol in obstructive sleep apnea: the effect of CPAP. Endocrine 40, 137–139 (2011)CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat C.M. Ghiciuc, L.C. Dima Cozma, R.M. Bercea et al., Restoring the salivary cortisol awakening response through nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chronobiol. Int. 30, 1024–1031 (2013)CrossRefPubMed C.M. Ghiciuc, L.C. Dima Cozma, R.M. Bercea et al., Restoring the salivary cortisol awakening response through nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chronobiol. Int. 30, 1024–1031 (2013)CrossRefPubMed
30.
Zurück zum Zitat B. Panaree, M. Chantana, S. Wasana, N. Chairat, Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels. Sleep Breath. 15, 649–656 (2011)CrossRefPubMed B. Panaree, M. Chantana, S. Wasana, N. Chairat, Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels. Sleep Breath. 15, 649–656 (2011)CrossRefPubMed
31.
Zurück zum Zitat G. Malakasioti, E.I. Alexopoulos, V. Varlami et al., Low morning serum cortisol levels in children with tonsillar hypertrophy and moderate-to-severe OSA. Sleep 36, 1349–1354 (2013)PubMedPubMedCentral G. Malakasioti, E.I. Alexopoulos, V. Varlami et al., Low morning serum cortisol levels in children with tonsillar hypertrophy and moderate-to-severe OSA. Sleep 36, 1349–1354 (2013)PubMedPubMedCentral
32.
Zurück zum Zitat K.M. Edwards, R. Kamat, L.M. Tomfohr, S. Ancoli-Israel, J.E. Dimsdale, Obstructive sleep apnea and neurocognitive performance: the role of cortisol. Sleep Med. 15, 27–32 (2014)CrossRefPubMed K.M. Edwards, R. Kamat, L.M. Tomfohr, S. Ancoli-Israel, J.E. Dimsdale, Obstructive sleep apnea and neurocognitive performance: the role of cortisol. Sleep Med. 15, 27–32 (2014)CrossRefPubMed
33.
Zurück zum Zitat G. Carneiro, S.M. Togeiro, L.F. Hayashi et al., Effect of continuous positive airway pressure therapy on hypothalamic–pituitary–adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am. J. Physiol. Endocrinol. Metab. 295, E380–E384 (2008)CrossRefPubMed G. Carneiro, S.M. Togeiro, L.F. Hayashi et al., Effect of continuous positive airway pressure therapy on hypothalamic–pituitary–adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am. J. Physiol. Endocrinol. Metab. 295, E380–E384 (2008)CrossRefPubMed
34.
Zurück zum Zitat Z. Karaca, S. Ismailogullari, S. Korkmaz et al., Obstructive sleep apnoea syndrome is associated with relative hypocortisolemia and decreased hypothalamo–pituitary–adrenal axis response to 1 and 250 μg ACTH and glucagon stimulation tests. Sleep Med. 14, 160–164 (2013)CrossRefPubMed Z. Karaca, S. Ismailogullari, S. Korkmaz et al., Obstructive sleep apnoea syndrome is associated with relative hypocortisolemia and decreased hypothalamo–pituitary–adrenal axis response to 1 and 250 μg ACTH and glucagon stimulation tests. Sleep Med. 14, 160–164 (2013)CrossRefPubMed
35.
Zurück zum Zitat C. Heim, U. Ehlert, D.H. Hellhammer, The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25, 1–35 (2000)CrossRefPubMed C. Heim, U. Ehlert, D.H. Hellhammer, The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25, 1–35 (2000)CrossRefPubMed
36.
Zurück zum Zitat G. Tirabassi, M. Boscaro, G. Arnaldi, Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine 46, 370–386 (2014)CrossRefPubMed G. Tirabassi, M. Boscaro, G. Arnaldi, Harmful effects of functional hypercortisolism: a working hypothesis. Endocrine 46, 370–386 (2014)CrossRefPubMed
37.
Zurück zum Zitat T.M. Buckley, A.F. Schatzberg, On the interactions of the hypothalamic–pituitary–adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab. 90, 3106–3114 (2005)CrossRefPubMed T.M. Buckley, A.F. Schatzberg, On the interactions of the hypothalamic–pituitary–adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab. 90, 3106–3114 (2005)CrossRefPubMed
38.
Zurück zum Zitat L. Plat, R. Leproult, M. L’Hermite-Baleriaux et al., Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J. Clin. Endocrinol. Metab. 84, 3082–3092 (1999)PubMed L. Plat, R. Leproult, M. L’Hermite-Baleriaux et al., Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J. Clin. Endocrinol. Metab. 84, 3082–3092 (1999)PubMed
39.
Zurück zum Zitat S. Dube, B.J. Norby, V. Pattan, R.E. Carter, A. Basu, R. Basu, 11β-Hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes. J. Clin. Endocrinol. Metab. 100, E70–E76 (2014)CrossRefPubMedCentral S. Dube, B.J. Norby, V. Pattan, R.E. Carter, A. Basu, R. Basu, 11β-Hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes. J. Clin. Endocrinol. Metab. 100, E70–E76 (2014)CrossRefPubMedCentral
40.
Zurück zum Zitat E.A. Lucassen, G. Cizza, The hypothalamic–pituitary–adrenal axis, obesity, and chronic stress exposure: sleep and the HPA axis in obesity. Curr. Obes. Rep. 1, 208–215 (2012)CrossRefPubMedPubMedCentral E.A. Lucassen, G. Cizza, The hypothalamic–pituitary–adrenal axis, obesity, and chronic stress exposure: sleep and the HPA axis in obesity. Curr. Obes. Rep. 1, 208–215 (2012)CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat D.M. Nathan, M.B. Davidson, R.A. DeFronzo et al., Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753–759 (2007)CrossRefPubMed D.M. Nathan, M.B. Davidson, R.A. DeFronzo et al., Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753–759 (2007)CrossRefPubMed
42.
Zurück zum Zitat D. Fisher, G. Pillar, A. Malhotra, N. Peled, P. Lavie, Long-term follow-up of untreated patients with sleep apnoea syndrome. Respir. Med. 96, 337–343 (2002)CrossRefPubMed D. Fisher, G. Pillar, A. Malhotra, N. Peled, P. Lavie, Long-term follow-up of untreated patients with sleep apnoea syndrome. Respir. Med. 96, 337–343 (2002)CrossRefPubMed
43.
Zurück zum Zitat A. Dawson, S.L. Abel, R.T. Loving et al., CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J. Clin. Sleep Med. 4, 538–542 (2008)PubMedPubMedCentral A. Dawson, S.L. Abel, R.T. Loving et al., CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J. Clin. Sleep Med. 4, 538–542 (2008)PubMedPubMedCentral
44.
Zurück zum Zitat T. Galic, J. Bozic, N. Ivkovic, T. Kurir Ticinovic, Z. Dogas, Effects of mandibular advancement device treatment on arterial stiffness and glucose metabolism in patients with mild to moderate obstructive sleep apnea: a prospective 1 year study. Sleep Breath. (2015). doi:10.1007/s11325-015-1186-y PubMed T. Galic, J. Bozic, N. Ivkovic, T. Kurir Ticinovic, Z. Dogas, Effects of mandibular advancement device treatment on arterial stiffness and glucose metabolism in patients with mild to moderate obstructive sleep apnea: a prospective 1 year study. Sleep Breath. (2015). doi:10.​1007/​s11325-015-1186-y PubMed
45.
Zurück zum Zitat E. Tasali, B. Mokhlesi, E. Van Cauter, Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133, 496–506 (2008)CrossRefPubMed E. Tasali, B. Mokhlesi, E. Van Cauter, Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133, 496–506 (2008)CrossRefPubMed
Metadaten
Titel
Morning cortisol levels and glucose metabolism parameters in moderate and severe obstructive sleep apnea patients
verfasst von
Josko Bozic
Tea Galic
Daniela Supe-Domic
Natalija Ivkovic
Tina Ticinovic Kurir
Zoran Valic
Josip Lesko
Zoran Dogas
Publikationsdatum
21.03.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0925-6

Weitere Artikel der Ausgabe 3/2016

Endocrine 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.